Levlad/Nature's Gate(R) Names Paddy Spence as President

Levlad/Nature's Gate(R) Names Paddy Spence as President Spence will be responsible for the company's branded and private label businesses and will serve as a member of the board of directors for Natural Products Group, LLC, the holding company for Levlad and Arbonne International.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales NPIcenter Makes Staying Ahead Easier With NPI Measures Monthly Recap and Analysis NPI Measures consolidates and puts into perspective the month's news and information published to NPIcenter, and is presented in both digital format and on-line in specially constructed zone. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Health Sciences Group Names Sid L. Anderson to Board of Directors Company announces the appointment of Mr. Sid L. Anderson to its Board of Directors, effective immediately, who will serve on audit committee. Health Sciences Group Names Sid L. Anderson to Board of Directors Company announces the appointment of Mr. Sid L. Anderson to its Board of Directors, effective immediately, who will serve on audit committee. Health Sciences Group Names Sid L. Anderson to Board of Directors Company announces the appointment of Mr. Sid L. Anderson to its Board of Directors, effective immediately, who will serve on audit committee. Health Sciences Group Names Sid L. Anderson to Board of Directors Company announces the appointment of Mr. Sid L. Anderson to its Board of Directors, effective immediately, who will serve on audit committee. SourceOne Announces Strategic Alliance with Chengdu Wagott Agreement will guarantee ability to meet growing global demand for Sytrinol SourceOne Announces Strategic Alliance with Chengdu Wagott Agreement will guarantee ability to meet growing global demand for Sytrinol SourceOne Announces Strategic Alliance with Chengdu Wagott Agreement will guarantee ability to meet growing global demand for Sytrinol Sunset Brands Enters Into Definitive Agreement to Acquire U.S. Mills Transaction is scheduled to close April 15, 2005. Sunset Brands Enters Into Definitive Agreement to Acquire U.S. Mills Transaction is scheduled to close April 15, 2005. Herbalife Names Three Additional Members to Board of Directors Leroy T. Barnes, Jr., Richard Bermingham and Peter Maslen will join the nine current members of the Board. Herbalife Names Three Additional Members to Board of Directors Leroy T. Barnes, Jr., Richard Bermingham and Peter Maslen will join the nine current members of the Board. Herbalife Names Three Additional Members to Board of Directors Leroy T. Barnes, Jr., Richard Bermingham and Peter Maslen will join the nine current members of the Board. Herbalife Names Three Additional Members to Board of Directors Leroy T. Barnes, Jr., Richard Bermingham and Peter Maslen will join the nine current members of the Board. Planet Organic to Acquire 17 Store Chain Company has signed a letter of intent to acquire Newfound Health, a profitable company with 17 franchise locations throughout Alberta. Planet Organic to Acquire 17 Store Chain Company has signed a letter of intent to acquire Newfound Health, a profitable company with 17 franchise locations throughout Alberta. Wild Oats Markets, Inc. Reports Preliminary Fourth Quarter and Year-End 2004 Results Company to restate prior period financial statements; will not have an impact on the Company's cash position, net sales or same-store sales. Preliminary 04 results show net sales of $1.05 billion, an 8.1 percent increase over net sales of $969.2 million in 2003. Comparable store sales in 2004 increased 1.4 percent. Wild Oats Markets, Inc. Reports Preliminary Fourth Quarter and Year-End 2004 Results Company to restate prior period financial statements; will not have an impact on the Company's cash position, net sales or same-store sales. Preliminary 04 results show net sales of $1.05 billion, an 8.1 percent increase over net sales of $969.2 million in 2003. Comparable store sales in 2004 increased 1.4 percent. NeuroNutrition, Inc., Forms Strategic Alliance With ProfileHealth In this agreement, NeuroNutrition will feature the HormoneProfile test kit produced by ProfileHealth and ProfileHealth will promote NeuroNutrition's line of products. NeuroNutrition, Inc., Forms Strategic Alliance With ProfileHealth In this agreement, NeuroNutrition will feature the HormoneProfile test kit produced by ProfileHealth and ProfileHealth will promote NeuroNutrition's line of products. Bio-One Removes CEO, Appoints Interim CEO Board has appointed Frank M. Clark as interim CEO, David G. Collins, C.P.A., Chairman of the Audit Committee, will serve as interim CFO. Bio-One Removes CEO, Appoints Interim CEO Board has appointed Frank M. Clark as interim CEO, David G. Collins, C.P.A., Chairman of the Audit Committee, will serve as interim CFO. Bio-One Removes CEO, Appoints Interim CEO Board has appointed Frank M. Clark as interim CEO, David G. Collins, C.P.A., Chairman of the Audit Committee, will serve as interim CFO. Bio-One Removes CEO, Appoints Interim CEO Board has appointed Frank M. Clark as interim CEO, David G. Collins, C.P.A., Chairman of the Audit Committee, will serve as interim CFO. Herbalife Ltd. Announces 2004 Net Sales Company announces sales increase of 13% to $1.3 billion while net income rose to $46.2 million compared to $36.8 million in 2003. Including pre-tax recapitalization expenses of $71.5 million, the company reported a net loss of $14.3 million, or 27 cents per share. Herbalife Ltd. Announces 2004 Net Sales Company announces sales increase of 13% to $1.3 billion while net income rose to $46.2 million compared to $36.8 million in 2003. Including pre-tax recapitalization expenses of $71.5 million, the company reported a net loss of $14.3 million, or 27 cents per share. Vital Living Acquires 100% Interest in Wellness Watchers Systems, LLC Company acquires 100% interest in Wellness Watchers Systems, LLC (WWS), formerly a 50/50 joint venture between Vital Living and Wellness Watchers International Inc. with product and service offerings to be integrated into Vital Living's wholly owned subsidiary, Doctors For Nutrition Inc. Vital Living Acquires 100% Interest in Wellness Watchers Systems, LLC Company acquires 100% interest in Wellness Watchers Systems, LLC (WWS), formerly a 50/50 joint venture between Vital Living and Wellness Watchers International Inc. with product and service offerings to be integrated into Vital Living's wholly owned subsidiary, Doctors For Nutrition Inc. Biogaia Signs Agreement In Hong Kong Company signs 5-year agreement with J Health Enterprise Ltd for exclusive rights to distribute Reuteri tablets in Hong Kong. Biogaia Signs Agreement In Hong Kong Company signs 5-year agreement with J Health Enterprise Ltd for exclusive rights to distribute Reuteri tablets in Hong Kong. Zila Strengthens Management Team Company announces appointment of Gary V. Klinefelter as Vice President and General Counsel. Zila Strengthens Management Team Company announces appointment of Gary V. Klinefelter as Vice President and General Counsel. Zila Strengthens Management Team Company announces appointment of Gary V. Klinefelter as Vice President and General Counsel. Zila Strengthens Management Team Company announces appointment of Gary V. Klinefelter as Vice President and General Counsel. Nestlé Full-Year Results Announced Company reports net profit up 8.1% to CHF 6.7 billion ($5.77 billion), as net debt reduced to CHF 10.2 billion from CHF 14.4 billion in 2003; consolidated sales reach CHF 86 769 million ($74.78 billion), EBITA reaches CHF 10 970 million. Nestlé Full-Year Results Announced Company reports net profit up 8.1% to CHF 6.7 billion ($5.77 billion), as net debt reduced to CHF 10.2 billion from CHF 14.4 billion in 2003; consolidated sales reach CHF 86 769 million ($74.78 billion), EBITA reaches CHF 10 970 million. Health Sciences Group Acquires Open Cell Biotechnologies, Inc. From UTEK Corporation Company acquires Open Cell Biotechnologies, Inc., a wholly-owned subsidiary of UTEK Corporation, in a stock transaction; OCBI holds the exclusive license from Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, to a patented process for the production of open-cell sponge food. Health Sciences Group Acquires Open Cell Biotechnologies, Inc. From UTEK Corporation Company acquires Open Cell Biotechnologies, Inc., a wholly-owned subsidiary of UTEK Corporation, in a stock transaction; OCBI holds the exclusive license from Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, to a patented process for the production of open-cell sponge food. United Natural Foods Announces Second Quarter Results Company reports net income of $9.4 million for the second quarter on sales for the second quarter of $504.7 million. United Natural Foods Announces Second Quarter Results Company reports net income of $9.4 million for the second quarter on sales for the second quarter of $504.7 million. Advanced Plant Pharmaceuticals Appoints Dr. Mechael Kanovsky as President of its Subsidiary Pharmaceutical Company Mazal Plant Pharmaceuticals Inc. Company announces the appointment of Dr. Mechael Kanovsky as President of Mazal Plant Pharmaceuticals Inc.; Mazel to focus on Clinical IND/ NDA development of Mazal's cholesterol drug formula into a targeted cholesterol /HDL and triglyceride drug. Advanced Plant Pharmaceuticals Appoints Dr. Mechael Kanovsky as President of its Subsidiary Pharmaceutical Company Mazal Plant Pharmaceuticals Inc. Company announces the appointment of Dr. Mechael Kanovsky as President of Mazal Plant Pharmaceuticals Inc.; Mazel to focus on Clinical IND/ NDA development of Mazal's cholesterol drug formula into a targeted cholesterol /HDL and triglyceride drug. Advanced Plant Pharmaceuticals Appoints Dr. Mechael Kanovsky as President of its Subsidiary Pharmaceutical Company Mazal Plant Pharmaceuticals Inc. Company announces the appointment of Dr. Mechael Kanovsky as President of Mazal Plant Pharmaceuticals Inc.; Mazel to focus on Clinical IND/ NDA development of Mazal's cholesterol drug formula into a targeted cholesterol /HDL and triglyceride drug. Advanced Plant Pharmaceuticals Appoints Dr. Mechael Kanovsky as President of its Subsidiary Pharmaceutical Company Mazal Plant Pharmaceuticals Inc. Company announces the appointment of Dr. Mechael Kanovsky as President of Mazal Plant Pharmaceuticals Inc.; Mazel to focus on Clinical IND/ NDA development of Mazal's cholesterol drug formula into a targeted cholesterol /HDL and triglyceride drug. Fonterra Lifts Bid for National Foods Company announces that it will top San Miguel Corporation’s offer for National Foods by 10 cents per share, increasing to 30 cents per share if it acquires 90% or more of National Foods; revised offer is at $6.00 per share, $6.20 if over 90%. Fonterra Lifts Bid for National Foods Company announces that it will top San Miguel Corporation’s offer for National Foods by 10 cents per share, increasing to 30 cents per share if it acquires 90% or more of National Foods; revised offer is at $6.00 per share, $6.20 if over 90%. Reliv International Reports 2004 Results Company reports 24% increase in net income, from $4.34 million or $0.26 per share diluted to $5.37 million or $0.31 per share diluted, on sales of $96.98 million compared to $76.96 million in 2003. Reliv International Reports 2004 Results Company reports 24% increase in net income, from $4.34 million or $0.26 per share diluted to $5.37 million or $0.31 per share diluted, on sales of $96.98 million compared to $76.96 million in 2003. Burcon Announces Third Quarter Results Company reports net loss of $637,306 ($0.04 per share) for FY05 Q3, compared to $579,818 ($0.04 per share) for same period in FY03. Burcon Announces Third Quarter Results Company reports net loss of $637,306 ($0.04 per share) for FY05 Q3, compared to $579,818 ($0.04 per share) for same period in FY03. NutraCea(R) Names Mr. David Bensol To Board Of Directors Mr. David Bensol, the former CEO of Critical Home Care has been appointed to NutraCea's Board of Directors. NutraCea(R) Names Mr. David Bensol To Board Of Directors Mr. David Bensol, the former CEO of Critical Home Care has been appointed to NutraCea's Board of Directors. NutraCea(R) Names Mr. David Bensol To Board Of Directors Mr. David Bensol, the former CEO of Critical Home Care has been appointed to NutraCea's Board of Directors. NutraCea(R) Names Mr. David Bensol To Board Of Directors Mr. David Bensol, the former CEO of Critical Home Care has been appointed to NutraCea's Board of Directors. Health Enhancement Products Appoints Thomas Ingolia to Head up Advisory Board; Steven Rittmanic Also Appointed to Advisory Board Company appoints Thomas D. Ingolia, President and CEO of Prolexys Pharmaceutical, Inc., to chair and recruit the members of a new advisory board. Health Enhancement Products Appoints Thomas Ingolia to Head up Advisory Board; Steven Rittmanic Also Appointed to Advisory Board Company appoints Thomas D. Ingolia, President and CEO of Prolexys Pharmaceutical, Inc., to chair and recruit the members of a new advisory board. Health Enhancement Products Appoints Thomas Ingolia to Head up Advisory Board; Steven Rittmanic Also Appointed to Advisory Board Company appoints Thomas D. Ingolia, President and CEO of Prolexys Pharmaceutical, Inc., to chair and recruit the members of a new advisory board. Health Enhancement Products Appoints Thomas Ingolia to Head up Advisory Board; Steven Rittmanic Also Appointed to Advisory Board Company appoints Thomas D. Ingolia, President and CEO of Prolexys Pharmaceutical, Inc., to chair and recruit the members of a new advisory board. Dynamic Health to Acquire Sports Nutrition and Performance Drink Distributor Company has entered into an agreement and plan of merger to acquire Dynamic Marketing, Inc. and will pay consideration in excess of $3 million, consisting of cash and stock. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	LOS ANGELES, Feb 22, 2005 /PRNewswire via COMTEX/ -- LEVLAD/NATURE'S GATE(R), one of the nation's leading manufacturers of natural personal care products (www.levlad.com) today announced the appointment of PADDY SPENCE as President. Spence will be responsible for the company's branded and private label businesses. He will also serve as a member of the board of directors for Natural Products Group, LLC, the holding company for Levlad and Arbonne International. Spence is the health and wellness industry's recognized authority on marketing and merchandising trends, and has led the effort to implement fact-based, strategic analysis of opportunities in this sector. He has authored articles on health and wellness trends for a variety of trade and academic publications, and is frequently quoted in the consumer media. Spence most recently served as Chairman of SPINS, a leading provider of health and wellness market research. An innovative and savvy entrepreneur, Spence founded SPINS to introduce sophisticated marketing information services to the rapidly growing health and wellness industry. Prior to founding SPINS, which he sold to private investors in 2004, Spence served as Vice President, sales & marketing for the Kashi Company, a manufacturer of natural cereals based in La Jolla, CA. He has also held positions at Harvard Business School's Division of Research, the Center for Leadership and Career Studies at Emory University and United Parcel Service's International Marketing department. "The addition of Paddy Spence to the Levlad team will greatly enhance our ability to continue providing the industry's highest levels of quality, innovation and customer service," states Steve Biroczky, Levlad's CEO. "We are excited that Paddy Spence has joined our management team and Board of Directors," says Michael DeFlorio, Managing Director of Harvest Partners, Inc., the majority owner of Levlad. "His strategic vision, broad consumer packaged goods industry expertise and proven leadership ability in high-growth companies will be important assets as we continue to expand Levlad's leadership position in the natural personal care market." Spence holds an A.B. from Harvard College and an M.B.A. from Harvard Business School. Levlad/Nature's Gate has become a household name when it comes to natural personal care. The CLASSICS, ORGANICS(R) and FRUIT BLEND(R) lines include shampoos, conditioners, lotions, shower gels, soaps, deodorants, moisturizing sticks, shave gels, lip balms, sunscreens and toothpastes. Levlad/Nature's Gate is located in Chatsworth, California. For more information, please contact Bette Light at (323) 650-2201 or at lightyearsahead@sbcglobal.net .
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software